Mabanal, Jessa .
HRN: 28-60-51 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/22/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/22/2026
02/22/2026
IV
4.5g
Loading Now
UTI
Checking Initial Appropriateness
02/22/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/22/2026
03/01/2026
IV
2.25g
Q8H
UTI
Checking Initial Appropriateness
03/18/2026
FLUCONAZOLE 150MG (CAP)
03/18/2026
03/25/2026
PO
160mg
OD
Mouth Sores
Checking Initial Appropriateness
03/18/2026
CEFTRIAXONE 1G (VIAL)
03/18/2026
03/25/2026
IV
2g
OD
HAP
Checking Initial Appropriateness
03/19/2026
FLUCONAZOLE 150MG (CAP)
03/19/2026
03/26/2026
PO
200mg
Od
Oral Candidiasis
Checking Initial Appropriateness
03/20/2026
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
03/20/2026
03/26/2026
ORAL
3cc
Q8
Mouth Ulcers
Checking Initial Appropriateness
03/20/2026
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
03/20/2026
03/26/2026
IV
200mg
Q24
Oral Candidiasis
Checking Initial Appropriateness